Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-16-149265)

Filing Details

Accession Number:: 0001209191-16-149265
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-11-10 13:53:39
Reporting Period:: 2016-11-09

Filing Date:: 2016-11-10
Accepted Time:: 2016-11-10 13:53:39
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1175505	Five Prime Therapeutics Inc	FPRX	Pharmaceutical Preparations (2834)	260038620

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1518724	Peder Jensen	Two Corporate Drive South San Francisco CA 94080		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-11-09	4,065	$5.54	4,065	No	4	M	Direct
Common Stock	Acquisiton	2016-11-09	4,065	$7.26	8,130	No	4	M	Direct
Common Stock	Disposition	2016-11-09	8,130	$55.30	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Acquisiton	2016-11-09	4,065	$0.00	4,065	$5.54
Common Stock	Stock Option (right to buy)	Acquisiton	2016-11-09	4,065	$0.00	4,065	$7.26

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2022-07-10	No	4	M	Direct
0		2023-07-18	No	4	M	Direct

Footnotes

The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on April 5, 2016.
This option is fully vested and immediately exercisable.